PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End Newswire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05 Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy Newswire
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 Peptide-ExplorerLT launched by Vapourtec ...aimed at chemists looking to explore and optimise linear peptide synthesis Vapourtec
16-Aug-2024 A-Level students urged to consider pharmaceutical careers Association of the British Pharmaceutical Industry (ABPI)
15-Aug-2024 Prognos Health Empowers Faster, More Targeted Interventions With New Daily HCP Alerts Offering Newswire
15-Aug-2024 Phastar named in 2024 Environment 100 List Phastar
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors PureTech Health plc
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
14-Aug-2024 NICE recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
14-Aug-2024 ViroCell Biologics completes oversubscribed financing ViroCell Biologics
14-Aug-2024 Kalm Therapeutics Emerges From Stealth With an Oversubscribed Seed Round Newswire
14-Aug-2024 Register now for Lab Innovations 2024 Lab Innovations
13-Aug-2024 Leapcure Acquires Honeybee Trials: Expanding Patient Engagement and Research Site Solutions for Clinical Trials Newswire
12-Aug-2024 MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor Newswire
09-Aug-2024 Valneva Scotland Receives Prestigious Award for Health and Safety Excellence Valneva
08-Aug-2024 Europe Investment Management Regulatory Reporting Market Analysis, Size, Share, Growth, Trends Forecasts 2023-2030 Metastat Insight and Technologies Pvt. Ltd.,
07-Aug-2024 Pharmanovia appoints new General Manager for the DACH region Pharmanovia